Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

NCT04211415 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision of termination of the clinical program.

Conditions

Atopic Dermatitis

Interventions

DRUG: DS-2741a
DRUG: Placebo

Sponsor

Daiichi Sankyo Co., Ltd.